Alto Neuroscience vs Guardant Health
Alto Neuroscience vs Guardant Health, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and Guardant Health on 57/100.
Where each one leads
Alto Neuroscience
Leads on none of the measures we hold for both companies.
Guardant Health
- our overall score: 57/100 against 43/100
- domain rating: 71/100 against 44/100
- headcount: 4,663 against 86
- funding raised: $900M against $370M
- LinkedIn following: 274,951 against 24,482
At a glance
| Measure | Alto Neuroscience | Guardant Health |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2012 |
| Headquarters | Los Altos, United States | Redwood City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alto Neuroscience | Guardant Health |
|---|---|---|
| Employees | 86 | 4,663 |
| Total funding | $370M | $900M |
| Latest round | Registered Direct Offering | Post IPO |
| LinkedIn followers | 24,482 | 274,951 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | Guardant Health |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 57/100 |
| Traction | 59/100 | 60/100 |
| Team | Not published | 10/100 |
| Community | 13/100 | Not published |
| Search visibility | 35/100 | 33/100 |
| Quality | 45/100 | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (51/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 71/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | Guardant Health |
|---|---|---|
| Hosting | Self Managed | AWS |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4, Google Tag Manager, Microsoft Clarity |
Alto Neuroscience vs Guardant Health: common questions
Which is better, Alto Neuroscience or Guardant Health?
On our 0-100 score Guardant Health rates higher (57/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and Guardant Health compare on the numbers?
Guardant Health leads on our overall score (57/100 against 43/100), domain rating (71/100 against 44/100), headcount (4,663 against 86), funding raised ($900M against $370M), LinkedIn following (274,951 against 24,482).
Read the full Alto Neuroscience review and pricing or the Guardant Health review and pricing. You can also browse other Alto Neuroscience alternatives we track.